|
04/10/2017 |
Bioequivalence of diclofenac sodium retard |
CIDEM |
Registered |
|
29/09/2017 |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
CENSA |
Registered |
|
27/09/2017 |
Bioequivalence of Abacavir |
CIDEM |
Registered |
|
05/09/2017 |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
CIM |
Registered |
|
15/08/2017 |
Bioactive formulation to treat osteoarthritis |
SSA |
Registered |
|
15/08/2017 |
Homeostec for chronic arthritis |
SSA |
Registered |
|
15/08/2017 |
Phenamate in the treatment of prostate cancer |
SSA |
Registered |
|
14/08/2017 |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
BIOCEN |
Registered |
|
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered |
|
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
|
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
|
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered |
|
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
|
17/02/2017 |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
CIM |
Registered |
|
17/02/2017 |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
|
17/02/2017 |
Paclitaxel/Radiotherapy/Cisplatino for cervical cancer |
SSA |
Registered |
|
16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
|
16/02/2017 |
CENTAURO-6 Study |
CIGB |
Registered |
|
16/02/2017 |
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
HGM |
Registered |
|
10/02/2017 |
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
CNCMA |
Registered |
